title: Virginal mammary hypertrophy: a meta-analysis and treatment algorithm.
abstract: BACKGROUND
  Virginal mammary hypertrophy, a rapid enlargement of one or both breasts that usually presents in the adolescent years, is a rare condition that has been reported sporadically in the medical literature. Currently, there are no patient- or disease-oriented evidence-based guidelines for the treatment of this condition. This meta-analysis examines the published case reports and presents a cumulative algorithm for the diagnosis and treatment of this uncommon condition.
  
  
  METHODS
  A literature search was performed using PubMed, with multiple keywords. Information regarding patient age, menarchal state, mass of excision, surgical technique, number of operations, pharmacologic intervention, and recurrence was extracted from each case report and analyzed using SPSS 15.1 statistical software.
  
  
  RESULTS
  A significant relationship was found (p < 0.01), as was an odds ratio of 7.0, for the likelihood of recurrence using a reduction mammaplasty as opposed to a mastectomy.
  
  
  CONCLUSIONS
  Based on the evidence presented in this article, certain interventions are more effective for the treatment of virginal mammary hypertrophy. On diagnosis of virginal mammary hypertrophy, tamoxifen therapy may be considered based on previous literature, barring any medical contraindications. A subcutaneous mastectomy with complete removal of breast tissue is the procedure least likely to lead to recurrence but is more deforming. Reduction mammaplasty gives an improved aesthetic breast, but it is important to counsel the patient on the likelihood of increased recurrence. Tamoxifen therapy following surgery may decrease the recurrence rate.
authors: Newark, N.J. From the Division of Plastic Surgery, Department of Surgery, and the Division of Endocrinology, Department of Pediatrics, New Jersey Medical School, University of Medicine and Dentistry of New Jersey.
authors: Ian C
authors: IC
authors: Hoppe
authors: Priti P
authors: PP
authors: Patel
authors: Carol J
authors: CJ
authors: Singer-Granick
authors: Mark S
authors: MS
authors: Granick
references: Koves IH, Zacharin M. Virginal breast hypertrophy of an 11-year-old girl. J Paediatr Child Health 2007;43:315–317.
references: Küçükaydin M, Kurtoğlu S, Okur H, et al. Virginal hypertrophy: Case report. Turk J Pediatr. 1994;36:243–248.
references: Morimoto T, Komaki K, Mori T, et al. Juvenile gigantomastia: Report of a case. Surg Today 1993;23:260–264.
references: Netscher DT, Mosharrafa AM, Laucirica R. Massive asymmetric virginal breast hypertrophy. South Med J. 1996;89:434–437.
references: Dancey A, Khan M, Dawson J, Peart F. Gigantomastia: A classification and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61:493–502.
references: Ağaoğlu G, Ozgür F, Erk Y. Unilateral virginal breast hypertrophy. Ann Plast Surg. 2000;45:451–453.
references: Al-Saif AA, Al-Yahya GM, Al-Qattan MM. Juvenile mammary hypertrophy: Is reduction mammaplasty always feasible? J Plast Reconstr Aesthet Surg. 2009;62:1470–1472.
references: Albert H. Diffuse idiopathic hypertrophy of the mammary glands of the female: A report of a new case and a consideration of the etiology and pathology based on data of recorded cases. JAMA 1910;55:1339–1343.
references: Arscott GD, Craig HR, Gabay L. Failure of bromocriptine therapy to control juvenile mammary hypertrophy. Br J Plast Surg. 2001;54:720–723.
references: Boyce SW, Hoffman PG Jr, Mathes SJ. Recurrent macromastia after subcutaneous mastectomy. Ann Plast Surg. 1984;13:511–518.
references: Cardoso de Castro C, Aboudib JH, Salema R, Valladares B. Massive breast hypertrophy in a young girl. Ann Plast Surg. 1990;25:497–501.
references: De Castro CC. Subcutaneous mastectomy for gigantomastia in an adolescent girl: Case report. Plast Reconstr Surg. 1977;59:575–578.
references: Erich JB. Plastic correction of excessive hypertrophy of the breasts at puberty: Report of a case. Proc Staff Meet Mayo Clin. 1960;35:192–194.
references: Fisher W, Smith JW. Macromastia during puberty. Plast Reconstr Surg. 1971;47:445–451.
references: Fisher G, Schauffler GC, Gurney CE, Bendshadler GH. Massive breast hypertrophy in adolescence. West J Obstet Gynecol. 1943;51:349–355.
references: Furnas DW. Subcutaneous mastectomy for juvenile hypertrophy of the breast: Report of a case. Br J Plast Surg. 1982;35:367–370.
references: Gaines J. Massive puberty hypertrophy of the breasts. Am J Obstet Gynecol. 1937;34:130–135.
references: Gerber B, Krause A, Lochmüller EM, Janni W, Friese K. Juvenile gigantomastia: Case report and literature survey (in German). Zentralbl Gynakol. 2004;126:167–169.
references: Gillespie JB, Hurter AJ. Virginal hypertrophy of the breast. J Pediatr. 1949;35:240–243.
references: Gliosci A, Presutti F. Virginal gigantomastia: Validity of combined surgical and hormonal treatments. Aesthetic Plast Surg. 1993;17:61–65.
references: Goodman BA. Mastitis gargantuan: An unusual case of puberty hypertrophy of the breasts. JAMA 1934;103:335–336.
references: Govrin-Yehudain J, Kogan L, Cohen HI, Falik-Zaccai TC. Familial juvenile hypertrophy of the breast. J Adolesc Health 2004;35:151–155.
references: Greig D. On pubertal mammary hypertrophy. Edinb Med J. 1922;28:153–167.
references: Güneş D, Mutafoğlu-Uysal K, Canda T, Saydam S, Cemeroğlu AP, Olgun N. Unilateral juvenile (virginal) hypertrophy of the breast. Turk J Pediatr. 2008;50:278–281.
references: Harris K, Rosenthal M. Virginal hypertrophy of the breast. Ariz Med. 1945;2:295–298.
references: Hollingsworth DR, Archer R. Massive virginal breast hypertrophy at puberty. Am J Dis Child. 1973;125:293–295.
references: Honan B. Note on a case of gigantism of breasts. Dublin J Med Sci. 1920;149:187.
references: Keyser L. Massive hypertrophy of the breast. Surg Gynecol Obstet. 1921;33:607–620.
references: Khan A, Mohammed-Emamdee R, Lalla R, Teelucksingh S, Perot S. Massive virginal breast hypertrophy. West Indian Med J. 2000;49:181–182.
references: Kupfer D, Dingman D, Broadbent R. Juvenile breast hypertrophy: Report of a familial pattern and review of the literature. Plast Reconstr Surg. 1992;90:303–309.
references: Mayl N, Vasconez LO, Jurkiewicz MJ. Treatment of macromastia in the actively enlarging breast. Plast Reconstr Surg. 1974;54:6–12.
references: Oberman HA. Breast lesions in the adolescent female. Pathol Annu. 1979;14:175–201.
references: O'Hare PM, Frieden IJ. Virginal breast hypertrophy. Pediatr Dermatol. 2000;17:277–281.
references: Pülzl P, Schoeller T, Tzankov A, Wechselberger G. Unilateral breast enlargement 5 years after reduction mammaplasty. Aesthetic Plast Surg. 2005;29:404–406.
references: Ryan RF, Pernoll ML. Virginal hypertrophy. Plast Reconstr Surg. 1985;75:737–742.
references: Sagot P, Mainguené C, Barrière P, Lopes P. Virginal breast hypertrophy at puberty; a case report. Eur J Obstet Gynecol Reprod Biol. 1990;34:289–292.
references: Samuelov R, Siplovich L. Juvenile gigantomastia. J Pediatr Surg. 1988;23:1014–1015.
references: Schumacher O, Ashkar W, Dabernig J, Nenadic I, Ingianni G. Juvenile gigantomastia of extreme magnitude: A case report. Ann Plast Surg. 2009;63:369–372.
references: Ship AG. Virginal and gravid mammary gigantism-recurrence after reduction mammaplasty. Br J Plast Surg. 1971;24:396–401.
references: Sperling RL, Gold JJ. Use of an anti-estrogen after a reduction mammaplasty to prevent recurrence of virginal hypertrophy of breasts: Case report. Plast Reconstr Surg. 1973;52:439–442.
references: Sridhar GR, Sinha MJ. Macromastia in adolescent girls. Indian Pediatr. 1995;32:496–499.
references: Wakeley C. Massive diffuse hypertrophy of the breasts in girls: A report of four cases. Practitioner 1934:608.
references: Wechselberger G, Pülzl P, Pichler M, Schoeller T, Piza-Katzer H. Juvenile gigantomastia treated by reduction mammoplasty. Am J Surg. 2004;188:333–334.
references: Wilkins L. The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. 3rd ed. Springfield, Ill: Thomas; 1965.
references: Noczyńska A, Wasikowa R, Myczkowski T. Hypersensitivity of estrogen receptors as a cause of gigantomasty in two girls (in Polish). Pol Merkur Lekarski. 2001;11:507–509.
references: Griffith JR. Virginal breast hypertrophy. J Adolesc Health Care 1989;10:423–432.
references: Li G, Robinson GW, Lesche R, et al. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 2002;129:4159–4170.
references: Kim TH, Wang J, Lee KY, et al. The synergistic effect of conditional Pten loss and oncogenic K-ras mutation on endometrial cancer development occurs via decreased progesterone receptor action. J Oncol. 2010:139087.
references: Daikoku T, Hirota Y, Tranguch S, et al. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008;68:5619–5627.
references: Hsieh SC, Chen NT, Lo SH. Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation. Mol Carcinog. 2009;48:545–552.
references: Kimura T, Suzuki A, Fujita Y, et al. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 2003;130:1691–1700.
references: Di Noto A, Pacheco BP, Vicala R, Itala J, Pellegrino J, Mendez Ribas J. Two cases of breast lymphoma mimicking juvenile hypertrophy. J Pediatr Adolesc Gynecol. 1999;12:33–35.
references: Touraine P, Youssef N, Alyanakian MA, et al. Breast inflammatory gigantomastia in a context of immune-mediated diseases. J Clin Endocrinol Metab. 2005;90:5287–5294.
references: Fiumara L, Gault DT, Nel MR, Lucas DN, Courtauld E. Massive bilateral breast reduction in an 11-year-old girl: 24% ablation of body weight. J Plast Reconstr Aesthet Surg. 2009;62:e263–e266.
references: Dietze EC, Troch MM, Bean GR, et al. Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity. Oncogene 2004;23:3851–3862.
references: Lipov EG, Joshi JR, Sanders S. A new mechanism of action for tamoxifen. Lancet Oncol. 2009;10:542.
references: Zacharin M. Current advances in bone health of disabled children. Curr Opin Pediatr. 2004;16:545–551.
references: Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr. 2004;145:71–76.
references: Singer-Granick CJ, Granick MS. Gynecomastia: What the surgeon needs to know. Eplasty 2009;9:e6.
references: Plourde PV, Reiter EO, Jou HC, et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: A randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:4428–4433.
references: Lee MC, Lehman JA Jr, Tantri MD, Parker MG, Wagner DS. Bilateral reduction mammoplasty in an adolescent population: Adolescent bilateral reduction mammoplasty. J Craniofac Surg. 2003;14:691–695.
references: Cruz NI, Korchin L. Lactational performance after breast reduction with different pedicles. Plast Reconstr Surg. 2007;120:35–40.